Arthroscopic vs. Open Bone Grafting for Scaphoid Delayed/Nonunion

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18-68
SponsorHerlev and Gentofte Hospital

About this trial

Single site, prospective, observer-blinded randomized controlled trial. Eighty-eight patients aged 18-68 years with scaphoid delayed/non-union, will be randomized, 1:1, to either open iliac crest cancellous graft reconstruction or arthroscopic assisted distal radius cancellous chips graft reconstruction. All Danish citizens, referred to the orthopedic department, Copenhagen University Hospital in Gentofte with scaphoid delayed/nonunion will be offered participation in the trial. Exclusion criteria are: Associated fracture in the hand/upper extremity, previous failed surgical treatment for scaphoid delayed/nonunion, stage 2 SNAC or above, avascular necrosis of the proximal pole and gross deformity.

Patients are stratified for smoking habits, proximal pole involvement, and displacement of \>/\<2mm. The primary outcome is time to union, measured with repeated CT scans at 2-week intervals from 6 to 16 weeks postoperatively. Secondary outcomes are Quick disabilities of the Arm, Shoulder and Hand (Q-DASH), Visual Analogue scale (VAS), donor site morbidity, union rate, restoration of scaphoid deformity, range of motion, key-pinch, grip strength, EQ5D-5L, patient satisfaction, complications, and revision surgery. Patients are examined before the operation and 1.5, 3, 6, 12 and 24 month after the operation. Online follow-up 5 and 10 years after surgery are performed.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patients aged 18-68 years.

A scaphoid fracture without healing 2-6 months since fracture (delayed union) for cases with either displacement >1mm or comminution and failed non-operative treatment.

Scaphoid fracture without healing >6 months since fracture (non-union) regardless of displacement, comminution and if previous non-operative treatment has been tried.

ASA 1-3.

Disqualifiers

Open fractures

Associated trans-scaphoid perilunate dislocation.

Associated fracture in the hand/upper extremity.

Previous failed surgical treatment for scaphoid delayed/non-union.

Trial design

Design model

Parallel

Treatments tested in this trial

  • Graft reconstruction and internal fixation with compression screw

    Procedure/Surgery

    Patients suffering from scaphoid nonunion are treated surgically by debridement, graft reconstruction and internal fixation with compression screw

Treatment groups

88 Participants
are divided into 2 treatment groups
Group A: Arthroscopic assisted Cancellous chips graft reconstructionExperimental treatment 1 intervention
Group B: Open cancellous graft reconstructionActive comparator 1 intervention

Trial outcomes

Primary outcomes

1

Time to Union

Assessed with CT-scans. Union is proclaimed if at least 50% bone bridging is recorded together with absence of pain in the clinical examination

Time frame
6-16 weeks postoperative in 2 weeks intervals. If unions is not achieved a CT will be made 26 weeks postoperatively. If union is not achieved at that point, the patient will be presented for another treatment modality

Secondary outcomes

1

The Quick Disability of the Arm, Shoulder, and Hand (Q-DASH)

Q Dash is a patient-reported survey. It is a subset of 11 items from the 30-item DASH questions that assess difficulties with specific tasks: 5 concerning symptoms, 4 on social function, and 1 on work function, sleep, and confidence. The score ranges from 0-100 and the higher score reflects disabilities. The MCID has been defined as 10.8 (range, 5-15) for comparable patients.

Time frame
Preoperatively, 1.5 md, 3md, 6md, 12md, 24md, 60md, and 120 months postoperative
2

Union rate

Assessed with CT-scans

Time frame
6-16 weeks postoperative. If unions is not achieved a CT will be made 26 weeks postoperatively
3

Correction of deformity

The Height length ratio (HLR) and dorsal cortical angle (DCA) are found to be the most reliable measurements to describe angulation. The height-length ratio is calculated by dividing the scaphoid height by length.

Time frame
Before surgery compared to CT-scan with >50% bone bridging.
4

Pain (VAS)

Pain at rest and activity is recorded on a visual analogue scale (VAS), ranging from 0-10, with 10 reflecting the worst and 0 representing no pain in the wrist.

Time frame
Preoperatively, 1.5, 3, 6, 12, 24, 60, and 120 months postoperative

Other outcomes

1

Patient satisfaction

is evaluated with the following question: What is the function of your hand today, compared to before surgery? With the following answer options: (1) disaster, (2) much worse, (3) slightly worse, (4) unchanged, (5) slightly better, (6) much better, (7) recovered. Secondary, for future research perspective patients are asked: When you consider the following parameters: The activities you can carry out in daily life, your pain, your function of the hand, do you think your current situation is satisfactory? (yes/no).

Time frame
Preoperatively, 1.5, 3, 6, 12, 24, 60, and 120 months postoperative
2

EQ5D-5L

will be used to estimate the threshold for acceptable cost-utility ratio - the threshold for how much health care providers will pay for an extra quality-adjusted life year (QALY). The cost utility of the Arthroscopic- and open technique will be compared. A cost model will be defined from patient data, clinical records, and unit costs from the Danish health care system. Length of hospital stay, discharge, pain medication usage and readmission will be recorded.

Time frame
Baseline and 2-year follow up scores will be compared
3

Complications and secondary surgery

We will record all complications related to the operative treatment (Tendon-, ligament-, nerve- or arterial injury, infection, complex regional pain syndrome, hematoma, or hardware failure). Reoperations, defined as revision surgery and secondary surgery due to no union will be noted.

Time frame
Preoperatively, 1.5, 3, 6, 12 and 24 months postoperative

Sponsors and contacts

Click on the lead sponsor to view all of their trials.